ICON Total Liabilities 2010-2024 | ICLR

ICON total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • ICON total liabilities for the quarter ending September 30, 2024 were $7.437B, a 7.88% decline year-over-year.
  • ICON total liabilities for 2023 were $7.749B, a 10.8% decline from 2022.
  • ICON total liabilities for 2022 were $8.687B, a 6.79% decline from 2021.
  • ICON total liabilities for 2021 were $9.32B, a 487.89% increase from 2020.
ICON Annual Total Liabilities
(Millions of US $)
2023 $7,749
2022 $8,687
2021 $9,320
2020 $1,585
2019 $1,250
2018 $1,000
2017 $956
2016 $881
2015 $954
2014 $579
2013 $532
2012 $448
2011 $354
2010 $280
2009 $336
ICON Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $7,437
2024-06-30 $7,384
2024-03-31 $7,616
2023-12-31 $7,749
2023-09-30 $8,072
2023-06-30 $8,311
2023-03-31 $8,633
2022-12-31 $8,687
2022-09-30 $8,887
2022-06-30 $8,890
2022-03-31 $9,094
2021-12-31 $9,320
2021-09-30 $9,686
2021-06-30 $1,557
2021-03-31 $1,532
2020-12-31 $1,585
2020-09-30 $1,354
2020-06-30 $1,280
2020-03-31 $1,327
2019-12-31 $1,250
2019-09-30 $1,208
2019-06-30 $1,190
2019-03-31 $1,185
2018-12-31 $1,000
2018-09-30 $991
2018-06-30 $936
2018-03-31 $1,014
2017-12-31 $956
2017-09-30 $926
2017-06-30 $875
2017-03-31 $911
2016-12-31 $881
2016-09-30 $909
2016-06-30 $840
2016-03-31 $952
2015-12-31 $954
2015-09-30 $950
2015-06-30 $614
2015-03-31 $606
2014-12-31 $579
2014-09-30 $562
2014-06-30 $527
2014-03-31 $524
2013-12-31 $532
2013-09-30 $508
2013-06-30 $491
2013-03-31 $463
2012-12-31 $448
2012-09-30 $416
2012-06-30 $421
2012-03-31 $424
2011-12-31 $354
2011-09-30 $348
2011-06-30 $302
2011-03-31 $321
2010-12-31 $280
2010-09-30 $291
2010-06-30 $284
2010-03-31 $312
2009-12-31 $336
2009-09-30 $381
2009-06-30 $390
2009-03-31 $376
Sector Industry Market Cap Revenue
Medical Medical Services $18.679B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00